Your session is about to expire
← Back to Search
VirtuaCare™ Platform for Shoulder Injuries
N/A
Recruiting
Led By Brian M Grawe, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial is studying a new device to improve at-home therapy adherence, as only 35% of patients follow their plans of care. The device provides instructions and real-time biofeedback to help patients adjust their form.
Who is the study for?
This trial is for patients who have had shoulder surgery performed by Dr. Brian Grawe and are prescribed outpatient physical therapy at UC Health. It's specifically for those with primary total or reverse total shoulder arthroplasty, or primary rotator cuff repair.Check my eligibility
What is being tested?
The study tests the BAND Connect's VirtuaCare™ platform against standard care in physical therapy adherence post-surgery. The VirtuaCare™ provides instructions and real-time biofeedback to help patients perform their exercises correctly at home.See study design
What are the potential side effects?
Since this trial involves a non-invasive technology aimed at improving exercise adherence, there aren't typical medical side effects. However, users may experience technical issues or frustration if they struggle with using the new device.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Visits
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group 1Experimental Treatment1 Intervention
Group 1 will be using the BAND CVCP both in the clinic and at home to supplement the treatment protocols used in the clinic today.
Group II: Group 2Placebo Group1 Intervention
Group 2 will receive standard-of-care physical therapy without the use of the BAND CVCP.
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,334 Total Patients Enrolled
Brian M Grawe, MDPrincipal InvestigatorUniversity of Cincinnati
1 Previous Clinical Trials
74 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Group 1
- Group 2: Group 2
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for people to enroll in this experiment?
"Clinicaltrials.gov has verified that this clinical trial is recruiting participants, with the initial post date being July 5th 2022 and last update on May 16th 2023."
Answered by AI
What is the participant quota for this clinical experiment?
"Affirmative. Clinicaltrials.gov's database reveals that this medical research, which had its inception on July 5th 2022, is currently seeking enrolment of 60 people from a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger